From 1 November 2026, changes will apply to certain Medicare Benefits Schedule (MBS) pathology services. The changes include streamline childhood syndrome testing, expanded NTRK1-3 testing and more options for double-stranded DNA antibody testing.

Further information can be found in the Factsheet below:

Word version - Factsheet -1 November 2026 Pathology Services Changes.DOCX
PDF version - Factsheet -1 November 2026 Pathology Services Changes.pdf